Jorge Martinez Romero 2019
Total Page:16
File Type:pdf, Size:1020Kb
UNIVERSIDAD AUTÓNOMA DE MADRID SCHOOL OF SCIENCES. DEPARTAMENT OF BIOLOGY Molecular anD computational approach to the link between nutrition anD cancer Jorge Martinez Romero 2019 Doctoral Thesis UNIVERSIDAD AUTÓNOMA DE MADRID SCHOOL OF SCIENCES DEPARTAMENT OF BIOLOGY CELLULAR BIOLOGY Imdea Food Research Institute Molecular Oncology Group TITLE: Molecular and computational approach to the link between nutrition and cancer Jorge Martínez Romero Doctoral THESIS Madrid, 2019 1 UNIVERSIDAD AUTÓNOMA DE MADRID FACULTAD DE CIENCIAS DEPARTAMENTO DE BIOLOGIA BIOLOGIA CELULAR Instituto Imdea Alimentación Grupo de Oncología Molecular TITULO: Molecular and computational approach to the link between nutrition and cancer Memoria presentada por: Jorge Martínez Romero Para optar al grado de DOCTOR EN BIOLOGÍA Directora: Dra. Ana Ramírez de Molina Codirector: Prof. Dr. Guillermo Reglero Rada Tutor: Prof. María José Hazen de San Juan Madrid, 2019 3 Drs. Ana Ramírez de Molina, PhD in Biochemistry and Molecular Biology at the University Autónoma de Madrid, and currently Deputy Director of the IMDEA Food Research Institute, Director of the Precision Nutrition and Cancer Program and Principal Investigator of the Molecular Oncology Group. As Director of this Thesis, Prof. Guillermo Reglero Rada, PhD in Chemistry, Full Professor of Food Sciences at the University Autónoma de Madrid and Senior Researcher of the Spanish National Research Council (CSIC). Currently he is the Director of the IMDEA Food Research Institute and Principal Investigator of the Food Products for Precision Nutrition Program. As co-director of this Thesis, INFORM: That the present work entitled “Molecular and computational approach to the link between nutrition and cancer” and that constitutes the Thesis presented by Mr. Jorge Martínez Romero to apply for the degree of Doctor in Biology, has been carried out at the Madrid Institute for Advanced Studies in Food (IMDEA Food),Spain; the Biomedical Research Center, National Institutes of Health (NIH), Baltimore, MD, USA; and the Cancer Research Center, Salamanca, Spain, under their direction. They consider that the experimental study is original, and the results have sufficient scientific quality for presentation as a Doctoral Thesis in the School of Science, Department of Biology, of the University Autónoma de Madrid. Thesis Director: PhD Ana Ramírez de Molina Thesis Codirector: Professor Guillermo Reglero Rada 5 Index 9 INDEX ACKNOWLEDGEMENTS .............................................................................................................................................................. 15 INDEX OF FIGURES AND TABLES ............................................................................................................................................. 21 LIST OF ABBREVIATIONS ............................................................................................................................................................ 27 SUMMARY ....................................................................................................................................................................................... 33 1. INTRODUCTION ............................................................................................................................................................... 39 1.1. CANCER. ..................................................................................................................................................................... 41 1.1.1. Cancer overview .................................................................................................................................................. 41 1.1.2. Colorectal cancer (CRC) ..................................................................................................................................... 48 1.1.3. Breast Cancer (BC) ............................................................................................................................................. 57 1.2. BIOINFORMATICS APPLIED TO GENOME-WIDE EXPRESSION TO ANALYZE THE CANCER GENOME ALTERATIONS. ...... 62 1.2.1. Functional genomics in cancer ........................................................................................................................... 62 1.3. NUTRITIONAL STRATEGIES IN CANCER BASED ON MOLECULAR EFFECTS: .................................................................. 69 1.3.1. Bioactive compounds: Phitochemicals, Phenolic compound Ellagic acid and derivatives in CRC. ............... 72 1.3.2. Caloric restriction and fasting in breast cancer. ................................................................................................ 78 2. HYPOTHESIS ....................................................................................................................................................................... 89 3. OBJECTIVES ........................................................................................................................................................................ 91 3.1. IDENTIFICATION OF GENES INVOLVED IN NUTRIENT SENSING OR CELL METABOLISM ASSOCIATED WITH CRC PROGNOSIS AND PATIENT SURVIVAL. ........................................................................................................................................... 91 3.2. IDENTIFICATION OF POTENTIAL PRECISION STRATEGIES IN CANCER FOCUSED ON MOLECULAR NUTRITION. .......... 91 3.2.1. Nutritional strategies based on the inclusion of bioactive compounds: Analysis of bioactive compounds with potential beneficial effect in CRC ........................................................................................................................................ 91 3.2.2. Nutritional strategies based on the inhibition of tumor nutrient requirements: Analysis of the inhibition of tumor progression and metastatic burden in BC through fasting strategies. .................................................................... 91 4. MATERIALS AND METHODS .......................................................................................................................................... 93 4.1. IN SILICO ANALYSIS: IDENTIFICATION OF GENES INVOLVED IN NUTRIENT SENSING OR CELL METABOLISM ASSOCIATED WITH CRC PROGNOSIS AND PATIENT SURVIVAL. ........................................................................................................................ 95 4.1.1. Dataset Integration and batch effect removal. ................................................................................................. 101 4.1.2. Batch effect removal evaluation. ....................................................................................................................... 102 4.1.3. Differential expression analysis......................................................................................................................... 103 4.1.4. Survival analysis ................................................................................................................................................. 103 4.1.5. Gene expression profiles of epithelial CRC samples vs CRC tumor samples. .............................................. 104 4.1.6. Geneset enrichment analysis (GSEA) .............................................................................................................. 105 4.2. IN VITRO ANALYSIS: ANALYSIS OF BIOACTIVE COMPOUNDS WITH POTENTIAL BENEFICIAL EFFECT IN CRC........... 106 4.2.1. Phenolic Compounds and Derived Metabolites .............................................................................................. 106 4.2.2. Cell Culture ....................................................................................................................................................... 106 4.2.3. Cell Viability Assays .......................................................................................................................................... 107 4.2.4. RNA Extraction and Quantification ................................................................................................................. 107 4.2.5. Gene Expression Assays .................................................................................................................................... 108 4.2.6. Real time qPCR ................................................................................................................................................. 108 4.2.7. Top-Fop tranfection assay ................................................................................................................................. 109 4.2.8. miRNAs Expression Assay ................................................................................................................................ 111 4.2.9. Cell Culture, Protein Extraction and Quantification ...................................................................................... 111 11 4.2.10. Western Blot analysis .................................................................................................................................. 111 4.2.11. Cell Migration Assay ................................................................................................................................... 113 4.2.12. Mitochondrial respiration and glycolytic function monitoring. ............................................................... 113 4.3. IN VIVO ANALYSIS: ANALYSIS OF THE INHIBITION OF TUMOR PROGRESSION AND METASTATIC BURDEN IN BC THROUGH